Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists

Stroke Research and Treatment
Carlos Estevez-FragaJaime Masjuan Vallejo

Abstract

Patients treated with vitamin K antagonists (VKA) are at increased risk of intracranial haemorrhage (ICH). The purpose of our study was to determine the quality of previous anticoagulation control in patients with VKA-associated ICH. We prospectively assessed every consecutive patient admitted to our stroke unit with VKA-associated ICH between 2013 and 2016. Demographic, clinical, and radiological variables, as well as consecutive international normalized ratios (INR) during 7 previous months, were extracted. Time in therapeutic range (TTR), time over range (TOR), time below range (TBR), and percentage of INR within range (PINRR) were calculated. The study population comprised 53 patients. Mean age was 79 years; 42% were women. Forty-eight patients had atrial fibrillation (AF) and 5 mechanical prosthetic valves. Therapeutic or infratherapeutic INR on arrival was detected in 64.4% of patients (95% CI 2.7 to 3.2). TTR was 67.8% (95% CI: 60.2 to 75.6 %) and PINRR was 75% (95% CI: 49.9-100). TOR was 17.2% (95% CI: 10.4 to 23.9% ) and TBR was 17% (95% CI: 10.6 to 23.9%). VKA-associated ICH happens usually in the context of good chronic anticoagulation control. Newer risk assessment methods are required.

References

Jun 1, 1994·Annals of Internal Medicine·E M Hylek, D E Singer
Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·R U KothariJ Khoury
Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Jun 28, 2008·Blood Reviews·Rebecca Appelboam, Elfyn O Thomas
Oct 15, 2008·Archives of Neurology·Alexander Y ZubkovAlejandro A Rabinstein
Jun 24, 2010·The American Journal of Medicine·Gregory Y H Lip, Jonathan L Halperin
Jan 6, 2011·Seminars in Neurology·Matthew L Flaherty
Nov 17, 2012·Lancet Neurology·Mark J AlbertsGraeme J Hankey
Jan 5, 2013·Stroke; a Journal of Cerebral Circulation·Nelly Dequatre-PonchelleCharlotte Cordonnier
Aug 21, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Marta Suárez-PinillaSergio Calleja-Puerta
Feb 25, 2014·Neurology·Daniela PoliUNKNOWN Italian Federation of Anticoagulation Clinics (FCSA)
Apr 24, 2014·Journal of the American Heart Association·Jonathan P PicciniUNKNOWN ROCKET AF Investigators
Jun 26, 2014·The New England Journal of Medicine·Tommaso SannaUNKNOWN CRYSTAL AF Investigators
Nov 26, 2015·Interventional Neurology·Gustavo Zapata-WainbergUNKNOWN representing the research team of the TAC Registry study

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Stata SE
Excel

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.